Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Neubauer

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
Annals of Hematology|February 2, 2022
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsElisabeth K M Mack, Sören Hartmann, Petra Ross, et al.
Haematologica|January 7, 2017
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with <i>RCSD1-ABL1</i>-positive acute lymphoblastic leukemiaMiriam Frech, Lutz B Jehn, Kathleen Stabla, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic LeukemiaJoerg Hoffmann, Semil Eminovic, Christian Wilhelm, et al.
Oncology Reports|July 6, 2007
Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cellsMihaela Kreutzer, Tanja Fauti, Kerstin Kaddatz, et al.
Blood|November 9, 2006
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activationYing Wang, Dali Cai, Cornelia Brendel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemiaAndreas Burchert, Martin C Müller, Philippe Kostrewa, et al.
Hemasphere|May 6, 2022
The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNAMiriam Rehberger, Jonas A Schäfer, Anna-Maria Krampitz, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 28, 2022
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella methodJoerg Hoffmann, Michael C Thrun, Maximilian A Röhnert, et al.
FEBS Letters|August 15, 2006
Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptorRobert Mandic, Chantal J Rodgarkia-Dara, Li Zhu, et al.
Blood|December 8, 2009
Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulinsVanessa J Craig, Isabelle Arnold, Christiane Gerke, et al.
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
Annals of Hematology|February 2, 2022
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsElisabeth K M Mack, Sören Hartmann, Petra Ross, et al.
Haematologica|January 7, 2017
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with <i>RCSD1-ABL1</i>-positive acute lymphoblastic leukemiaMiriam Frech, Lutz B Jehn, Kathleen Stabla, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic LeukemiaJoerg Hoffmann, Semil Eminovic, Christian Wilhelm, et al.
Oncology Reports|July 6, 2007
Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cellsMihaela Kreutzer, Tanja Fauti, Kerstin Kaddatz, et al.
Blood|November 9, 2006
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activationYing Wang, Dali Cai, Cornelia Brendel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemiaAndreas Burchert, Martin C Müller, Philippe Kostrewa, et al.
Hemasphere|May 6, 2022
The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNAMiriam Rehberger, Jonas A Schäfer, Anna-Maria Krampitz, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 28, 2022
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella methodJoerg Hoffmann, Michael C Thrun, Maximilian A Röhnert, et al.
FEBS Letters|August 15, 2006
Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptorRobert Mandic, Chantal J Rodgarkia-Dara, Li Zhu, et al.
Blood|December 8, 2009
Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulinsVanessa J Craig, Isabelle Arnold, Christiane Gerke, et al.
Pageof 23